Treatment trial of multicentric reticulohistiocytosis with a combination of predonisolone, methotrexate and alendronate.
Satoh
Masataka
M
Oyama
Noritaka
N
Yamada
Hitoshi
H
Nakamura
Koichiro
K
Kaneko
Fumio
F
D000328:Adult; D019386:Alendronate / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D015616:Histiocytosis, Non-Langerhans-Cell / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D050071:Bone Density Conservation Agents; D011239:Prednisolone; D019386:Alendronate; D008727:Methotrexate